Whistleblower bags $96 million for flagging problems at Glaxo plant

10/30/2010 | Wall Street Journal, The

A GlaxoSmithKline quality-assurance manager named Cheryl Eckard has bagged a $96 million bounty for blowing the whistle on problems at the company's manufacturing plant in Puerto Rico. The company ultimately paid $750 million to settle a criminal case arising from the whistleblower's report, which highlighted dosing problems stemming from the plant's practice of mixing drugs of varying strengths in the same bottles. "This is not something I ever wanted to do, but I felt I had no choice because of the safety concerns," Eckard said.

View Full Article in:

Wall Street Journal, The

Published in Brief: